FDA FY 1996 budget flat in Senate Cmte. measure; bill set for floor debate Sept. 18.
This article was originally published in The Gray Sheet
Executive Summary
FDA FY 1996 APPROPRIATIONS BILL SENATE FLOOR CONSIDERATION tentatively scheduled for Sept. 18, following approval by the Senate Appropriations Committee Sept. 14 and the Agriculture Subcommittee the previous day. The committee adopted the flat funding levels for FDA that were approved by the House in July ("The Gray Sheet" July 24, In Brief).
You may also be interested in...
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.